| Antigen | A 20-aa peptide from the middle region of human RAMP2 (protein accession #O60895) and A 9-aa peptide of Human RAMP2; the peptide mixture is Designated as (RAMP21-P) or blocking peptide) |
| Form | Affinity purified IgG |
| Product Type | Primary Antibodies |
| SpCrossreactivity | Human RAMP21-P peptides are 50% and 89% conserved in mouse and rat, 63% in pig RAMP2. However, no significant sequence homology is detected with other RAMPs. Antibody cross-reactivity in various species has not been studied |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |